Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Other Non-Current Liabilities (2017 - 2025)

Historic Other Non-Current Liabilities for Cartesian Therapeutics (RNAC) over the last 10 years, with Q3 2025 value amounting to $848000.0.

  • Cartesian Therapeutics' Other Non-Current Liabilities fell 7638.54% to $848000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848000.0, marking a year-over-year decrease of 7638.54%. This contributed to the annual value of $3.8 million for FY2024, which is 4000.63% down from last year.
  • Cartesian Therapeutics' Other Non-Current Liabilities amounted to $848000.0 in Q3 2025, which was down 7638.54% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Other Non-Current Liabilities ranged from a high of $45.5 million in Q1 2021 and a low of $848000.0 during Q3 2025
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $13.1 million (2023), whereas its average is $17.0 million.
  • As far as peak fluctuations go, Cartesian Therapeutics' Other Non-Current Liabilities surged by 23611.75% in 2023, and later crashed by 8527.0% in 2025.
  • Over the past 5 years, Cartesian Therapeutics' Other Non-Current Liabilities (Quarter) stood at $25.4 million in 2021, then fell by 24.71% to $19.1 million in 2022, then plummeted by 66.59% to $6.4 million in 2023, then tumbled by 40.01% to $3.8 million in 2024, then crashed by 77.89% to $848000.0 in 2025.
  • Its Other Non-Current Liabilities was $848000.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $2.0 million in Q1 2025.